Table 3. Sub-analysis in malignant or borderline diseases.
| Characteristic | miRNAs panel negative (n=163), n (%) | miRNAs panel positive (n=84), n (%) | P |
|---|---|---|---|
| Gender | 0.498 | ||
| Male | 96 (58.9) | 45 (53.6) | |
| Female | 67 (41.1) | 39 (46.4) | |
| Age (years) | 0.828 | ||
| ≤70 | 145 (89.0) | 76 (90.5) | |
| >70 | 18 (11.0) | 8 (9.5) | |
| Smoker | 0.277 | ||
| Smoker | 90 (55.2) | 53 (63.1) | |
| Non-smoker | 73 (44.8) | 31 (36.9) | |
| GGNs or nodules size (mm) | 0.007 | ||
| ≤8 | 85 (52.1) | 28 (33.3) | |
| >8 | 78 (47.9) | 56 (66.7) | |
| Number of lung GGNs or nodules | 0.446 | ||
| ≤3 | 123 (75.5) | 59 (70.2) | |
| >3 | 40 (24.5) | 25 (29.8) | |
| GGNs or nodules | 0.128 | ||
| GGNs | 68 (41.7) | 26 (31.0) | |
| Nodules | 95 (58.3) | 58 (69.0) |
GGN, glass ground nodule.